Greater occipital nerve blocks with bupivacaine in the treatment of chronic migraine. Randomized, multicenter, double-blind, parallel, placebo-controlled study

被引：0
|
作者：
Inan, L. [1 ]
Inan, N. [2 ]
Karadas, O. [3 ]
Gul, H. L. [4 ]
Erdemoglu, A. K. [5 ]
Turkel, Y. [5 ]
Akyol, A. [6 ]
机构：
[1] Ankara Educ & Res Hosp, Ankara, Turkey
[2] Gazi Univ, Fac Med, Ankara, Turkey
[3] Mevki Hastanesi, Ankara, Turkey
[4] Lutfi Kirdar Res & Training Hosp, Istanbul, Turkey
[5] Kirikkale Univ, Kirikkale, Turkey
[6] Adnan Menderes Univ, Aydin, Turkey
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OS2109
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [1] Greater occipital nerve blocks with bupivacaine in the treatment of chronic migraine: randomized, multicenter, double-blind, parallel, placebo-controlled study
    Inan, L.
    Inan, N.
    Karadas, O.
    Gul, H. L.
    Erdemoglu, A. K.
    Turkel, Y.
    Akyol, A.
    JOURNAL OF NEUROLOGY, 2014, 261 : S39 - S39
  • [2] Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study
    Inan, L. E.
    Inan, N.
    Karadas, O.
    Gul, H. L.
    Erdemoglu, A. K.
    Turkel, Y.
    Akyol, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 132 (04): : 270 - 277
  • [3] Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study
    Chowdhury, Debashish
    Tomar, Apoorva
    Deorari, Vaibhav
    Duggal, Ashish
    Krishnan, Anand
    Koul, Arun
    CEPHALALGIA, 2023, 43 (02)
  • [4] Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial
    Cuadrado, Maria L.
    Aledo-Serrano, Angel
    Navarro, Patricia
    Lopez-Ruiz, Pedro
    Fernandez-de-las-Penas, Cesar
    Gonzalez-Suarez, Ines
    Orviz, Aida
    Fernandez-Perez, Cristina
    CEPHALALGIA, 2017, 37 (09) : 864 - 872
  • [5] Short-term effects of greater occipital nerve blockades in chronic migraine: a double-blind, randomized, placebo-controlled clinical trial
    Cuadrado, M. L.
    Aledo-Serrano, A.
    Navarro, P.
    Fernandez-Perez, C.
    Gonzalez-Suarez, I.
    Galan, L.
    Orviz, A.
    Fernandez-de-las-Penas, C.
    CEPHALALGIA, 2015, 35 : 33 - 34
  • [6] Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double-blind placebo-controlled clinical trial
    Nabaei, Ghaemeh
    CEPHALALGIA, 2023, 43 (1supp) : 226 - 226
  • [7] Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double-blind placebo-controlled clinical trial
    Malekian, Nazila
    Bastani, Pouya B.
    Oveisgharan, Shahram
    Nabaei, Ghaemeh
    Abdi, Siamak
    CEPHALALGIA, 2022, 42 (06) : 481 - 489
  • [8] Greater occipital and supraorbital nerve blockade for the preventive treatment of migraine: a single-blind, randomized, placebo-controlled study
    Ozer, Duygu
    Boluk, Cem
    Boru, Ulku Turk
    Altun, Deniz
    Tasdemir, Mustafa
    Toksoy, Cansu Koseoglu
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 909 - 915
  • [9] The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study
    Gul, H. L.
    Ozon, A. O.
    Karadas, O.
    Koc, G.
    Inan, L. E.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (02): : 138 - 144
  • [10] Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
    Detke, Holland C.
    Goadsby, Peter J.
    Wang, Shufang
    Friedman, Deborah I.
    Selzler, Katherine J.
    Aurora, Sheena K.
    NEUROLOGY, 2018, 91 (24) : E2211 - E2221
12345